Blinatumomab Improves Survival in Measurable Residual Disease Negative Acute Lymphoblastic Leukemia
An updated analysis of the phase 3 E1910 clinical trial demonstrates that blinatumomab consolidation improves survival in patients with B-cell ...
An updated analysis of the phase 3 E1910 clinical trial demonstrates that blinatumomab consolidation improves survival in patients with B-cell ...
A combined local search and genetic algorithm improved cancer classification accuracy and reduced computational complexity across more than 30,000 patient ...
A prospective pilot study shows that symptom-guided home blood transfusions for hospice patients with hematologic malignancies are safe and feasible, ...
A phase 1 trial found that a pill of 16 selected beneficial bacteria was safe for stem cell transplant patients ...
A phase 2 randomized trial found favorable biological, clinical and exploratory survival signals from vitamin C in pre-cancer blood disorders, ...
Researchers in Barcelona report that a six-gene activity score, anchored by the Polycomb factor PHF19, divides acute myeloid leukaemia patients ...
A systematic review of 20 qualitative studies finds that blood cancer patients often experience hematopoietic stem cell transplantation as a ...
University of Nottingham researchers have discovered that a common leukaemia mutation disrupts how the NPM1 protein docks onto chromosomes during ...
Blood Cancer United has awarded $2.5 million to a Columbia University team to test AI-assisted identification and patient navigation strategies ...
A University of Gothenburg study finds that one in four adults hospitalized with invasive pneumococcal disease carried M protein, leading ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.